Novartis has announced plans to acquire Tourmaline Bio, strengthening its cardiovascular pipeline...
Category - Biotechnology
Libtayo Plus Chemotherapy Delivers Five-Year Survival Benefit in...
Regeneron Pharmaceuticals, Inc. has announced five-year follow-up results from its Phase 3 EMPOWER...
Glycomine Begins Global Phase 2b Clinical Trial of GLM101 for...
Glycomine, Inc., a clinical-stage biotechnology company, has announced the initiation of dosing in...
SeqOne to Acquire Congenica to Establish Global Leader in AI...
SeqOne has entered into a definitive agreement to acquire Congenica, the UK genomics company spun...
AbbVie shares Phase 2 EPCORE® NHL-6 data: outpatient first-full...
AbbVie has reported updated results from the Phase 2 EPCORE® NHL-6 study (NCT05451810) assessing...
Roche Receives CE Mark for Contivue Port Delivery Platform in...
Roche has announced that the European Union has granted CE Mark approval for Contivue®, its Port...
NoPalm Ingredients and NIZO Launch First Yeast Oil Demonstration...
NoPalm Ingredients has partnered with NIZO to establish the first yeast oil demonstration factory...
Trinity Biotech Reports Breakthrough Clinical Trial Results for...
Trinity Biotech has announced positive clinical trial results for its newly redesigned continuous...
Bayer Presents VICTOR Phase III Results for Vericiguat in Heart...
Bayer has shared new data from the VICTOR Phase III vericiguat heart failure trial in patients with...
Boehringer Ingelheim and AnGes Sign Manufacturing Agreement for...
Boehringer Ingelheim and AnGes have strengthened their long-standing collaboration with a new...